4.4 Article

Nesfatin-1 increases anxiety- and fear-related behaviors in the rat

Journal

PSYCHOPHARMACOLOGY
Volume 201, Issue 1, Pages 115-123

Publisher

SPRINGER
DOI: 10.1007/s00213-008-1252-2

Keywords

Nesfatin-1; Anxiety; Fear; Elevated plus maze; Novelty; Fear-potentiated startle; Conditioned emotional response

Funding

  1. Canadian Institutes of Health Research (CIHR)
  2. Natural Science and Engineering Research Council of Canada (NSERC)

Ask authors/readers for more resources

Rationale Nesfatin-1, derived from the protein NEFA/nucleobindin2 (NUCB2), is a newly identified peptide that acts as a potent satiety agent. It has been reported that peptides involved in the regulation of ingestive behavior are also involved in the regulation of the stress response. However, the relation between nesfatin-1 and stressor-related behaviors like anxiety and/or fear has not yet been investigated. Objective The effects of intracerebroventricular (ICV) injection of nesfatin-1 (0, 5, and 25 pmol/3 mu l) were assessed in several paradigms that are thought to reflect anxiety and/or fear in rats. Results Consistent with an anxiogenic effect, nesfatin-1 dose-dependently decreased the percentage of time spent on the open arms of the elevated plus maze, increased latency to approach, and decreased consumption of a palatable snack in an anxiogenic (unfamiliar) environment. Moreover, ICV nesfatin-1 increased the fear-potentiated startle response and the time spent freezing to both context and conditioned cues in a conditioned emotional response test. Conclusions These findings suggest that in addition to its role as a satiety peptide, nesfatin-1 may also be involved in the mediation of anxiety- and/or fear-related responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available